Skip to content

Effectiveness of dutasteride plus minoxidil solution vs minoxidil solution alone in male pattern hair loss

Comparison of efficacy of topical 0.025 % Dutasteride plus 5 % Minoxidil solution vs topical Minoxidil 5 % alone in male androgenetic alopecia - a randomised open label pilot study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/063225
Enrollment
60
Registered
2024-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: Topical dutasteride 0.025% plus 5% minoxidil solution: 1ml of topical dutasteride 0.025% at morning time plus 1 ml of topical 5% minoxidil solution at night time daily for 24 weeks Cont

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All males aged 18-45 yrs of age 2. Males with (Hamilton Norwood Scale II-IV) 3. Who are not currently undergoing any hair treatment and have not undergone any in the last 3 months

Exclusion criteria

Exclusion criteria: 1.Severe hypertension, moderate hypertension on antihypertensive therapy. 2.Cardiovascular dysfunction 3.History of minoxidil hypersensitivity 4.Patients with a history of hypersensitivity to the active ingredient, to other 5-alpha reductase inhibitors 5.Psychiatric or scalp disease

Design outcomes

Primary

MeasureTime frame
1. Clinical photographic assessment and quantitative assessment using densitometer 2. Hair density calculationTimepoint: every monthly for 6 months

Secondary

MeasureTime frame
The number of vellus hairs, terminal hairs determined by their thickness in the specific square inch areaTimepoint: every monthly for 6 months

Countries

India

Contacts

Public ContactBikash Ranjan Kar

IMS and SUM Hospital

karbikash@gmail.com9937428181

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026